Haregewein Assefa

432 total citations
11 papers, 358 citations indexed

About

Haregewein Assefa is a scholar working on Molecular Biology, Infectious Diseases and Computational Theory and Mathematics. According to data from OpenAlex, Haregewein Assefa has authored 11 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Computational Theory and Mathematics. Recurrent topics in Haregewein Assefa's work include Computational Drug Discovery Methods (3 papers), HER2/EGFR in Cancer Research (2 papers) and Cannabis and Cannabinoid Research (2 papers). Haregewein Assefa is often cited by papers focused on Computational Drug Discovery Methods (3 papers), HER2/EGFR in Cancer Research (2 papers) and Cannabis and Cannabinoid Research (2 papers). Haregewein Assefa collaborates with scholars based in United States, Poland and Ethiopia. Haregewein Assefa's co-authors include John K. Buolamwini, Shantaram Kamath, Robert D. Sindelar, Larry Walker, Alison Nimrod, Jarosław Sławiński, Nouri Neamati, Z Brzozowski, Franciszek Sączewski and Zvi G. Loewy and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Haregewein Assefa

11 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haregewein Assefa United States 9 168 140 102 79 53 11 358
Flavio Ballante United States 15 330 2.0× 165 1.2× 161 1.6× 55 0.7× 28 0.5× 25 519
Giorgio Amendola Italy 15 250 1.5× 159 1.1× 104 1.0× 55 0.7× 18 0.3× 32 467
Jintong Du China 9 251 1.5× 100 0.7× 75 0.7× 43 0.5× 27 0.5× 17 385
István Káldor United States 11 123 0.7× 219 1.6× 37 0.4× 111 1.4× 72 1.4× 21 482
Caleb Foster United States 12 333 2.0× 131 0.9× 52 0.5× 40 0.5× 45 0.8× 13 528
Valeria Famiglini Italy 15 161 1.0× 273 1.9× 30 0.3× 121 1.5× 65 1.2× 18 461
Palani Kirubakaran India 12 262 1.6× 58 0.4× 116 1.1× 34 0.4× 17 0.3× 22 416
Matthew D. Selby United Kingdom 12 215 1.3× 284 2.0× 21 0.2× 49 0.6× 34 0.6× 22 492
Andrew J. McRiner United States 10 261 1.6× 236 1.7× 79 0.8× 62 0.8× 6 0.1× 17 528
Ian Stansfield United Kingdom 15 272 1.6× 203 1.4× 40 0.4× 177 2.2× 19 0.4× 23 745

Countries citing papers authored by Haregewein Assefa

Since Specialization
Citations

This map shows the geographic impact of Haregewein Assefa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haregewein Assefa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haregewein Assefa more than expected).

Fields of papers citing papers by Haregewein Assefa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haregewein Assefa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haregewein Assefa. The network helps show where Haregewein Assefa may publish in the future.

Co-authorship network of co-authors of Haregewein Assefa

This figure shows the co-authorship network connecting the top 25 collaborators of Haregewein Assefa. A scholar is included among the top collaborators of Haregewein Assefa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haregewein Assefa. Haregewein Assefa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Assefa, Haregewein, et al.. (2022). Autism and associated disorders: cannabis as a potential therapy. Frontiers in Bioscience-Elite. 14(1). 1–1. 11 indexed citations
2.
Assefa, Haregewein, et al.. (2016). Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy. Parkinson s Disease. 2016. 1–19. 18 indexed citations
3.
Assefa, Haregewein. (2014). Ebola Virus Potential Drug Targets and Prospects for Small Molecule Drug Discovery. 1(4). 313–321. 1 indexed citations
4.
Draper, Michael P., Beena Bhatia, Haregewein Assefa, et al.. (2013). In Vitro and In Vivo Antimalarial Efficacies of Optimized Tetracyclines. Antimicrobial Agents and Chemotherapy. 57(7). 3131–3136. 10 indexed citations
5.
Donkor, Isaac O., Haregewein Assefa, & Jiuyu Liu. (2008). Structural Basis for the Potent Calpain Inhibitory Activity of Peptidyl α-Ketoacids. Journal of Medicinal Chemistry. 51(14). 4346–4350. 13 indexed citations
6.
Buolamwini, John K. & Haregewein Assefa. (2003). Overview of Novel Anticancer Drug Targets. Humana Press eBooks. 85. 3–28. 1 indexed citations
7.
Assefa, Haregewein, Shantaram Kamath, & John K. Buolamwini. (2003). 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Journal of Computer-Aided Molecular Design. 17(8). 475–493. 51 indexed citations
8.
Assefa, Haregewein, Shantaram Kamath, Z Brzozowski, et al.. (2003). Application of CoMFA and CoMSIA 3D-QSAR and Docking Studies in Optimization of Mercaptobenzenesulfonamides as HIV-1 Integrase Inhibitors. Journal of Medicinal Chemistry. 47(2). 385–399. 64 indexed citations
9.
Buolamwini, John K. & Haregewein Assefa. (2002). CoMFA and CoMSIA 3D QSAR and Docking Studies on Conformationally-Restrained Cinnamoyl HIV-1 Integrase Inhibitors:  Exploration of a Binding Mode at the Active Site. Journal of Medicinal Chemistry. 45(4). 841–852. 124 indexed citations
10.
Assefa, Haregewein, Alison Nimrod, Larry Walker, & Robert D. Sindelar. (2001). Enantioselective Synthesis and Complement Inhibitory Assay of A/B-Ring Partial Analogues of Oleanolic Acid. Bioorganic & Medicinal Chemistry Letters. 11(13). 1619–1623. 25 indexed citations
11.
Assefa, Haregewein, Alison Nimrod, Larry Walker, & Robert D. Sindelar. (1999). Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid. Bioorganic & Medicinal Chemistry Letters. 9(14). 1889–1894. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flavio Ballante Breakdown of academic impact, for papers by Giorgio Amendola Breakdown of academic impact, for papers by Jintong Du Breakdown of academic impact, for papers by István Káldor Breakdown of academic impact, for papers by Caleb Foster Breakdown of academic impact, for papers by Valeria Famiglini Breakdown of academic impact, for papers by Palani Kirubakaran Breakdown of academic impact, for papers by Matthew D. Selby Breakdown of academic impact, for papers by Andrew J. McRiner Breakdown of academic impact, for papers by Ian Stansfield
Rankless by CCL
2026